Codex

The People

Governance grade: B-. Everest Industries is a promoter-controlled company with a strong independent board, but the recent simultaneous departure of the CEO and CFO during a period of weak profitability raises execution and succession risk. Alignment is maintained through majority promoter ownership, though the promoter family holds no direct equity and the professional management team has limited personal skin in the game.

The People Running This Company

Everest is controlled by Padmini Sekhsaria through Falak Investment Private Limited (50.15% stake). She is the ultimate beneficial owner and daughter of Narotam Sekhsaria, founder of Ambuja Cements – one of India's most successful building materials entrepreneurs. The company is transitioning leadership: Rajesh Joshi resigned as MD and CEO effective September 12, 2025 after approximately four years, and Hemant Khurana (ex-Saint-Gobain Weber) took over on September 13, 2025. The CFO also turned over in early 2025, adding to management instability.

Anant Talaulicar is the strongest governance asset on this board. He was Chairman and Managing Director of Cummins Group in India for 13 years (2004–2017), a large-cap industrial business with a strong governance reputation. He has been actively involved in Everest's strategy, not merely a figurehead chairman. His commission of ~₹80.5 lakh for FY25 reflects an engaged role, though its magnitude relative to other NEDs requires annual shareholder approval.

Padmini Sekhsaria does not hold shares directly but controls 50.15% through Falak Investment. She sits on boards of Narotam Sekhsaria Foundation and Ambuja Foundation, indicating continued family involvement in the broader Sekhsaria business ecosystem. Her remuneration is limited to sitting fees (₹2.8 lakh in FY25), suggesting she exercises control primarily through the board structure rather than operational involvement.

What They Get Paid

Rajesh Joshi's total pay fell 20% from ₹398L to ₹318L because no variable compensation was paid for FY25. His fixed salary increased 6.5%, but the variable component – which was ₹100L in FY24 – went to zero, directly reflecting the company's weak profitability year. This is the pay-for-performance mechanism working as intended.

Hemant Khurana's incoming package is structured more aggressively: ₹3 Cr fixed annually, up to ₹7.2 Cr variable over 3 years (tied to Revenue Growth and ROCE targets), a ₹50 lakh signing bonus, and 30,000 ESOPs. His variable targets are demanding – for example, revenue growth of 9-15% and ROCE of 5-15% over FY26-28. This structure correctly emphasizes both growth and capital efficiency.

Chairman pay concentration is notable. Talaulicar's commission of ₹80.5L exceeds 50% of total NED remuneration, requiring annual special resolution approval. For a ~₹530 Cr market cap company, a ₹2 Cr commission cap for a non-executive chairman is generous – but given his operational involvement and caliber (ex-Cummins CMD), it is not unreasonable.

The median employee remuneration increase was 8.4%, while managerial remuneration did not increase. The MD-to-median ratio is 41.4x, which is moderate for an industrial company of this size.

Are They Aligned?

Ownership and Control. Falak Investment's 50.15% gives the promoter group absolute control. The promoter holding has been stable – Falak held 79,33,409 shares in both FY24 and FY25, with no increase or decrease. This stability is positive. MIT (Massachusetts Institute of Technology) holds 9.86% as an anchor institutional investor, also with stable holdings.

Insider Activity. No insider buying or selling was reported during FY25. The absence of insider purchases during a period when the stock fell from ~₹750 to ~₹285 (a 60%+ decline) is a missed opportunity for management to demonstrate conviction. Neither the promoter nor the outgoing MD bought shares at these depressed valuations.

Dilution. The ESOS-2021 scheme authorized 10,00,000 options. As of March 2025, 5,77,037 have been granted and 4,22,963 remain. With 3,92,529 options outstanding, potential dilution is ~2.5% of current equity (1,58,19,880 shares). The exercise prices range from ₹580 to ₹1,189 – all significantly above the current share price of ~₹335 – meaning these options are deeply underwater and not an immediate dilution concern. The scheme is being extended (removing the Mar 2025 grant deadline) and broadened to include subsidiary employees.

Related-Party Transactions. All FY25 RPTs were exclusively with wholly-owned subsidiaries and conducted at arm's length. There were no transactions with the promoter/promoter group holding 10%+ of shares. The only promoter-related flow was Falak receiving ₹198.34L in dividend (proportional to its holding). The company has extended ₹93.35 Cr in inter-corporate deposits to Everest Buildpro (subsidiary building the new Karnataka plant) and provided a ₹140 Cr corporate guarantee. These are business-purpose flows to WOS entities, not related-party extraction.

Capital Allocation. Dividend of ₹2.50/share (FY25) vs ₹2.50 (FY24) and ₹6.00 (FY23). The dividend cut from FY23 levels reflects the profitability decline and is prudent given the capex cycle (₹138 Cr Assam plant approved). Total equity of ~₹623 Cr supports the balance sheet.

Skin-in-the-Game Score: 5/10. The promoter family controls a majority stake but holds zero direct shares. Professional management has minimal personal ownership. The ESOP program is small relative to the float. No insider buying during a steep stock price decline is a negative signal. The promoter's financial alignment comes through Falak Investment's capital at risk, which at current prices represents ~₹266 Cr in value, providing meaningful alignment. However, the layer of separation (private holding company) and absence of direct personal buying caps this score at the middle of the range.

Board Quality

Board composition is strong on paper. Four of seven directors (57%) are independent, meeting SEBI norms. Two of seven (29%) are women. The board refreshed significantly in FY24, adding Ashok Barat (CA/CS) and Bijal Ajinkya (international tax lawyer) after M.L. Gupta and B.L. Taparia retired after completing two terms.

Independence is genuine. Rajendra Chitale chairs the Audit Committee and is a well-known Mumbai-based chartered accountant with regulatory panel experience. Ashok Barat brings CA/CS credentials and governance depth. Bijal Ajinkya (Khaitan and Co. partner) adds legal rigor. None of these independent directors appear to have pre-existing business relationships with the Sekhsaria family based on available disclosures.

Missing expertise: The board lacks a dedicated technology/digital transformation expert and a deep operations/supply-chain specialist from the building materials sector (beyond the incoming MD). Given Everest's ongoing plant expansion and operational turnaround, an independent director with large-scale manufacturing operations background would be valuable.

Board meetings: Only 4 meetings in FY25 (the minimum required). For a company undergoing a leadership transition and profitability challenges, a higher meeting frequency would have been appropriate.

Compliance: All recommendations of the Audit Committee were accepted by the Board. No SEBI penalties or regulatory actions were disclosed. The Secretarial Audit report did not contain qualifications. The statutory auditor (SRBC and Co. LLP) is a reputable Big 4 affiliate.

The Verdict

Strongest positives:

Promoter Falak Investment holds a stable 50.15% with zero pledge and zero encumbrance. The board has been materially refreshed in FY24 with credible independent directors. Anant Talaulicar as Chairman brings genuine operational engagement and a strong personal reputation from Cummins India. Related-party transactions are clean – exclusively with WOS entities. Pay-for-performance worked: the MD received zero variable comp in a weak year.

Real concerns:

Simultaneous CEO and CFO departures in 2025 during a period of near-zero consolidated profitability signal either management dissatisfaction or organizational stress. The new MD's package is well-structured but untested. The promoter family's indirect holding through a private vehicle, combined with zero insider buying during a 60%+ stock decline, signals passive financial alignment rather than active conviction. The board met only 4 times during a turbulent year.

What would most likely cause an upgrade or downgrade:

Upgrade to B+/A-: If Hemant Khurana demonstrates operational traction (hitting FY26 ROCE targets of 4-6%), if the promoter or management makes meaningful open-market share purchases, and if the board increases meeting frequency during the transition period. Downgrade to C+: If the new MD departs within 18 months, if the Assam/Karnataka subsidiary capex projects burn cash without revenue traction, or if any undisclosed related-party flows emerge between the promoter family entities and the company.